Dan Sheng
Directeur/Bestuurslid bij BEIJING STRONG BIOTECHNOLOGIES,INC.
Vermogen: 907 594 $ op 30-04-2024
Actieve functies van Dan Sheng
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Directeur/Bestuurslid | 13-08-2020 | - |
| Corporate Officer/Principal | 01-12-2016 | - | |
Fuzhou Maixin Biotech Co., Ltd.
 Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Directeur/Bestuurslid | 30-09-2020 | - |
Loopbaan van Dan Sheng
Opleiding van Dan Sheng
| University of Science & Technology of China | Undergraduate Degree |
| New York University | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Services | 2 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BEIJING STRONG BIOTECHNOLOGIES,INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Fuzhou Maixin Biotech Co., Ltd.
Fuzhou Maixin Biotech Co., Ltd. Medical/Nursing ServicesHealth Services Part of Beijing Strong Biotechnologies, Inc., Fuzhou Maixin Biotech Co., Ltd. engages in the production, research & development, and sales of tissue-based diagnostics, specifically IHC antibodies, reagents, and the automation of IHC and ISH. The company is based in Fuzhou, China. Fuzhou Maixin Biotech Co. was acquired by Fuzhou Maixin Biotech Co. Ltd. /Private Group/ on September 30, 2020 for $255.21 million. The Chinese company was founded in 1993. The CEO is Xiao Ya Wang. | Health Services |
